Ellex could hit $2

Ellex has the potential to be a stellar stock. There are several drivers of medium term share price growth
1. Growing sales of its traditional products such as ultrasound, photodisruption and SLT. This will be further enhanced by a rapidly growing presence in China
2. The move to new facilities and production capacity expansion (early 2017)
3. A likely fall in the AUD over the next two years
4. The growing acceptance of itrack. Glaukos (NASDAQ: GKOS) has a similar but probalby inferior product as their main item. Yet this company has a capitalisation of over $Au 1.5 billion
5. The likely success of 2RT. Early trials are positive. If the 3 year results (due out in late 2018) come out positive then this would be a gamechanger for the treatment of AMDlikely valuing Ellex in the billions.

All these factors mean that Ellex could hit $2 in the next 12 months